[
  {
    "ts": null,
    "headline": "How The Narrative Surrounding Hologic (HOLX) Has Shifted With The US$79 All Cash Buyout",
    "summary": "Hologic’s fair value estimate has been nudged from US$76.92 to US$76.60, a small shift that keeps it closely aligned with the proposed US$79 all cash takeout price. This fine tuning mainly reflects the way analysts are anchoring their models to the agreed deal terms, with only modest tweaks to the discount rate and revenue growth assumptions, while the share price tracks closer to the offer. If you are following this story, it is worth staying tuned to see how and when these valuation inputs...",
    "url": "https://finnhub.io/api/news?id=07874d778694dfcca471ed424086e349487d1dfb9f63287ed3412733408bd3ee",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770930728,
      "headline": "How The Narrative Surrounding Hologic (HOLX) Has Shifted With The US$79 All Cash Buyout",
      "id": 139074990,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HOLX",
      "source": "Yahoo",
      "summary": "Hologic’s fair value estimate has been nudged from US$76.92 to US$76.60, a small shift that keeps it closely aligned with the proposed US$79 all cash takeout price. This fine tuning mainly reflects the way analysts are anchoring their models to the agreed deal terms, with only modest tweaks to the discount rate and revenue growth assumptions, while the share price tracks closer to the offer. If you are following this story, it is worth staying tuned to see how and when these valuation inputs...",
      "url": "https://finnhub.io/api/news?id=07874d778694dfcca471ed424086e349487d1dfb9f63287ed3412733408bd3ee"
    }
  }
]